Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title | Descriptor ▼ |
|---|---|---|---|
| 7KQI | 7KQI | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
| 7KQI | A4D5Q0 | Antibodies that engage the hemagglutinin receptor-binding site of influenza B viruses | |
| 7KR6 | A0A1Y4PXW9 | Glycoside hydrolase family 16 endo-glucanase from Bacteroides ovatus in complex with G4G3G-2F-DNP | |
| 7KS9 | P0DTC2 | Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab | |
| 7KS9 | 7KS9 | Cryo-EM structure of prefusion SARS-CoV-2 spike glycoprotein in complex with 910-30 Fab | |
| 7KUY | P23416 | Cyro-EM structure of human Glycine Receptor alpha2-beta heteromer, strychnine bound state | |
| 7KUY | P42212 | Cyro-EM structure of human Glycine Receptor alpha2-beta heteromer, strychnine bound state | |
| 7KUY | P48167 | Cyro-EM structure of human Glycine Receptor alpha2-beta heteromer, strychnine bound state | |
| 7KV3 | A0A173VPY3 | Surface glycan-binding protein A from Bacteroides thetaiotaomicron in complex with laminarihexaose | |
| 7KV6 | F3PPH3 | Surface glycan-binding protein B from Bacteroides fluxus in complex with mixed-linkage glucotriose | |
| 7KV7 | F3PPH3 | Surface glycan-binding protein B from Bacteroides fluxus in complex with laminaritriose | |
| 7KV8 | A0A1X9PLJ6 | Chimeric flavivirus between Binjari virus and Dengue virus serotype-2 | |
| 7KV8 | A0A7D0JW86 | Chimeric flavivirus between Binjari virus and Dengue virus serotype-2 | |
| 7KV9 | A0A0U2IWM5 | Chimeric flavivirus between Binjari virus and West Nile (Kunjin) virus | |
| 7KV9 | A0A0A6ZKT6 | Chimeric flavivirus between Binjari virus and West Nile (Kunjin) virus | |
| 7KVA | A0A0U2IWM5 | Structure of West Nile virus (Kunjin) | |
| 7KVA | A0A0A6ZKT6 | Structure of West Nile virus (Kunjin) | |
| 7KVB | A0A023J5I3 | Chimeric flavivirus between Binjari virus and Murray Valley encephalitis virus | |
| 7KVB | A0A059ZZ36 | Chimeric flavivirus between Binjari virus and Murray Valley encephalitis virus | |
| 7KX0 | P32970 | Crystal structure of the CD27:CD70 co-stimulatory complex | |
| 7KX0 | P26842 | Crystal structure of the CD27:CD70 co-stimulatory complex | |
| 7KXJ | P0DTC2 | SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric | |
| 7KXJ | 7KXJ | SARS-CoV-2 spike protein in complex with Fab 15033-7, 3-"up", asymmetric | |
| 7KXK | P0DTC2 | SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation | |
| 7KXK | 7KXK | SARS-CoV-2 spike protein in complex with Fab 15033-7, 2-"up"-1-"down" conformation | |
| 7KZ5 | C0JRF5 | Crystal structure of KabA from Bacillus cereus UW85 in complex with the plp external aldimine adduct with kanosamine-6-phosphate | |
| 7KZB | 7KZB | Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1antibodies | |
| 7KZB | P0DTC2 | Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1antibodies | |
| 7L0J | P03971 | Structure of AMH bound to AMHR2-ECD | |
| 7L0J | Q16671 | Structure of AMH bound to AMHR2-ECD | |
| 7L0N | 7L0N | Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity | |
| 7L0N | Q9BYF1 | Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity | |
| 7L0N | P0DTC2 | Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity | |
| 7L2C | P0DTC2 | Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-terminal domain (NTD) | |
| 7L2C | 7L2C | Crystallographic structure of neutralizing antibody 2-51 in complex with SARS-CoV-2 spike N-terminal domain (NTD) | |
| 7L8C | 7L8C | BG505 SOSIP MD39 in complex with the polyclonal Fab pAbC-3 from animal Rh.33104 (Wk26 time point) | |
| 7L8S | 7L8S | BG505 SOSIP.v5.2(7S) in complex with the polyclonal Fab pAbC-4 from animal Rh.33172 (Wk38 time point) | |
| 7L8X | 7L8X | BG505 SOSIP.v5.2 N241/N289 in complex with the polyclonal Fab pAbC-4 from animal Rh.33311 (Wk26 time point) | |
| 7LAB | P0DTC2 | Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052 | |
| 7LAB | 7LAB | Structure of SARS-CoV-2 S protein in complex with N-terminal domain antibody DH1052 | |
| 7LBL | Q6PYX1 | Structure of Human IgG1 Fc | |
| 7LFL | Q31093 | MODEL OF MHC CLASS Ib H2-M3 WITH MOUSE ND1 N-TERMINAL HEPTAPEPTIDE, VAL MUTANT, MONOCLINIC CELL, REFINED AT 1.60 ANGSTROMS RESOLUTION | |
| 7LFL | P01887 | MODEL OF MHC CLASS Ib H2-M3 WITH MOUSE ND1 N-TERMINAL HEPTAPEPTIDE, VAL MUTANT, MONOCLINIC CELL, REFINED AT 1.60 ANGSTROMS RESOLUTION | |
| 7LFL | P03888 | MODEL OF MHC CLASS Ib H2-M3 WITH MOUSE ND1 N-TERMINAL HEPTAPEPTIDE, VAL MUTANT, MONOCLINIC CELL, REFINED AT 1.60 ANGSTROMS RESOLUTION | |
| 7LR6 | C2GY91 | Crystal structure of GH5_18-E140A from Bifidobacterium longum subsp. longum ATCC 55813 in complex with Manb1-4GlcNAc | |
| 7LWM | P0DTC2 | Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation | |
| 7LWO | P0DTC2 | Mink Cluster 5-associated SARS-CoV-2 spike protein (S-GSAS-D614G-delFV) in the 1-RBD up conformation | |
| 7LWT | P0DTC2 | UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation | |
| 7LWU | P0DTC2 | UK (B.1.1.7) SARS-CoV-2 spike protein variant (S-GSAS-B.1.1.7) in the 1-RBD-up conformation | |
| 7LY3 | P0DTC2 | Crystal structure of SARS-CoV-2 S NTD bound to S2M28 Fab |
